|
|
||||||||
From the Department of Neurology (Dr. Broussolle), and CERMEP Cyclotron Unit (Drs. Broussolle and Ginovart), Hôpital Neurologique Pierre Wertheimer, Lyon; INSERM U 289 (Drs. Lücking and Dürr), Hôpital de la Salpêtrière, Paris; Department of Clinical and Biological Neurosciences (Dr. Pollak), Hôpital Nord, Grenoble; and Service Hospitalier Frédéric Joliot (Dr. Remy), Orsay, France.
Address correspondence and reprint requests to Dr. Emmanuel Broussolle, Service de Neurologie D, Hôpital Neurologique Pierre Wertheimer, 59 boulevard Pinel, 69003, Lyon, France.
Article abstractParkin gene mutations cause a form of early-onset autosomal recessive PD with neuronal loss in the substantia nigra and no Lewy bodies. The authors present a PET [18F]-dopa study of one familial and two sporadic cases with juvenile-onset PD resulting from parkin gene mutations. They found a profound decrease of [18F]-dopa uptake, representing 28% of putamen and 44% of caudate nucleus control subject values. PD caused by parkin gene mutations is distinct from idiopathic PD on molecular grounds but has similar clinical and PET findings.
This article has been cited by other articles:
![]() |
F. Binkofski, K. Reetz, C. Gaser, R. Hilker, J. Hagenah, K. Hedrich, T. van Eimeren, A. Thiel, C. Buchel, P. P. Pramstaller, et al. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia Neurology, August 28, 2007; 69(9): 842 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Adams, H. van Netten, M. Schulzer, E. Mak, J. Mckenzie, A. Strongosky, V. Sossi, T. J. Ruth, C. S. Lee, M. Farrer, et al. PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation Brain, December 1, 2005; 128(12): 2777 - 2785. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Beilina, M. Van Der Brug, R. Ahmad, S. Kesavapany, D. W. Miller, G. A. Petsko, and M. R. Cookson Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability PNAS, April 19, 2005; 102(16): 5703 - 5708. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Atadzhanov, A Zumla, and P Mwaba Study of familial Parkinson's disease in Russia, Uzbekistan, and Zambia Postgrad. Med. J., February 1, 2005; 81(952): 117 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varrone, M. T. Pellecchia, M. Amboni, V. Sansone, E. Salvatore, D. Ghezzi, B. Garavaglia, A. Brice, A. Brunetti, V. Bonavita, et al. Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkin disease Neurology, December 14, 2004; 63(11): 2097 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Scherfler, N. L. Khan, N. Pavese, L. Eunson, E. Graham, A. J. Lees, N. P. Quinn, N. W. Wood, D. J. Brooks, and P. P. Piccini Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism Brain, June 1, 2004; 127(6): 1332 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thobois, M.-J. Ribeiro, E. Lohmann, A. Durr, P. Pollak, O. Rascol, S. Guillouet, E. Chapoy, N. Costes, Y. Agid, et al. Young-Onset Parkinson Disease With and Without Parkin Gene Mutations: A Fluorodopa F 18 Positron Emission Tomography Study Arch Neurol, May 1, 2003; 60(5): 713 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Khan, D. J. Brooks, N. Pavese, M. G. Sweeney, N. W. Wood, A. J. Lees, and P. Piccini Progression of nigrostriatal dysfunction in a parkin kindred: an [18F]dopa PET and clinical study Brain, October 1, 2002; 125(10): 2248 - 2256. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.T. Portman, N. Giladi, K.L. Leenders, P. Maguire, L. Veenma-van der Duin, J. Swart, J. Pruim, E.S. Simon, S. Hassin-Baer, and A.D. Korczyn The nigrostriatal dopaminergic system in familial early onset parkinsonism with parkin mutations Neurology, June 26, 2001; 56(12): 1759 - 1762. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |